Drug Profile
SAR 441169
Alternative Names: Retinoid orphan receptor gamma t inhibitors - Lead Pharma/Sanofi; ROR gamma t inhibitors - Lead Pharma/Sanofi; SAR441169Latest Information Update: 06 Aug 2021
Price :
$50
*
At a glance
- Originator Lead Pharma
- Developer Sanofi
- Class Antipsoriatics; Small molecules
- Mechanism of Action Nuclear receptor subfamily 1 group F member 3 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Psoriasis